Sinopharm Group Co. Ltd. (HKG:1099)
17.50
-0.36 (-2.02%)
Apr 24, 2025, 4:08 PM HKT
Sinopharm Group Employees
Sinopharm Group had 108,217 employees as of December 31, 2024. The number of employees decreased by 7,742 or -6.68% compared to the previous year.
Employees
108,217
Change (1Y)
-7,742
Growth (1Y)
-6.68%
Revenue / Employee
5.75M HKD
Profits / Employee
69.32K HKD
Market Cap
54.61B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 108,217 | -7,742 | -6.68% |
Dec 31, 2023 | 115,959 | 1,193 | 1.04% |
Dec 31, 2022 | 114,766 | 1,532 | 1.35% |
Dec 31, 2021 | 113,234 | 4,918 | 4.54% |
Dec 31, 2020 | 108,316 | 14,552 | 15.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Innovent Biologics | 5,659 |
Akeso | 3,035 |
Alibaba Health Information Technology | 1,435 |
CSPC Pharmaceutical Group | 21,400 |
Sinopharm Group News
- 7 days ago - Sinopharm Group: Mixed Read-Throughs From Peer Disclosures And Management Guidance - Seeking Alpha
- 5 months ago - Sinopharm Group: The Focus Is On Working Capital And Profitability - Seeking Alpha
- 7 months ago - How AI and Sinopharm’s disruptive technologies are contributing to longer human life - The Times of India
- 4 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 4 years ago - Week In Review: WHO Close To Approving Global Use For 2 China COVID-19 Vaccines - Seeking Alpha
- 4 years ago - Diversifying Into Top-Ranked Sinopharm - Seeking Alpha
- 4 years ago - Week In Review: Sinopharm Transfers $4.6 Billion In Assets Including Two COVID-19 Vaccines - Seeking Alpha
- 4 years ago - Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs - Seeking Alpha